Pfizer

Pfizer Inc and its German partner BioNTech SE said on Friday their Omicron-tailored shot produced higher virus-neutralizing antibodies in older adults against the emerging subvariant BQ.1.1 than its original vaccine. Antibody levels…
Read More...

A new study by Pfizer and BioNTech suggests that its updated Covid-19 booster is better than its predecessor at increasing the antibody levels of people older than 55 against the most common version of the virus now circulating. Federal…
Read More...

Pfizer expects to roughly quadruple the price of its Covid-19 vaccine to about US$110 to US$130 (S$157-S$185) per dose after the United States government’s current purchase programme expires, Pfizer executive Angela Lukin said on Thursday.…
Read More...

Pfizer Inc and its German vaccine partner said their booster tailored to the latest Omicron variants raised more antibodies against the dominant strains of Covid-19, compared with the original shot designed to fight the form of the virus.…
Read More...

Today, Tuesday, the US “Pfizer” submitted a request to the US Food and Drug Administration for emergency permission to provide a fourth dose of the “Covid-19” vaccine to Americans 65 years of age and older. Pfizer provided data on the…
Read More...

South Korea on Thursday received its first supply of Pfizer’s antiviral COVID-19 pills to treat patients with mild or moderate symptoms. Health officials have described the Paxlovid pills as a potentially important tool to suppress…
Read More...

Egypt authorized on Sunday Pfizer’s COVID-19 vaccine for children aged 12-15, the cabinet said in a statement. The step effectively lowers the minimum age of eligibility to receive the two-shot vaccine in Egypt, which was 15 years old…
Read More...

Gulf state Bahrain has approved the Pfizer COVID-19 vaccine for emergency use for children aged between 5 and 11 years, the government media office said on Tuesday. The decision came after a study involving 3,100 children aged between 5…
Read More...

The United Arab Emirates has approved for emergency use the Pfizer-BioNtech COVID-19 vaccine for children aged 5-11, the health ministry said in a statement carried by state media on Monday. Before this decision the only vaccine that had…
Read More...

Pfizer and BioNTech announced Thursday they would seek regulatory authorization for a third dose of their Covid-19 vaccine. It comes after initial data from an ongoing trial showed a third shot pushed antibody levels five to 10 times…
Read More...